Leonteq Securities AG’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75K Sell
17
-2
-11% -$130 ﹤0.01% 1158
2026
Q1
$903 Sell
19
-1,481
-99% -$66.4K ﹤0.01% 1196
2025
Q4
$47.6K Hold
1,500
﹤0.01% 958
2025
Q3
$42.2K Hold
1,500
﹤0.01% 913
2025
Q2
$55.2K Hold
1,500
﹤0.01% 830
2025
Q1
$58.9K Buy
+1,500
New +$67.6K ﹤0.01% 808
2024
Q3
Sell
-154
Closed -$7.59K 1275
2024
Q2
$7.59K Hold
154
﹤0.01% 1013
2024
Q1
$5.28K Hold
154
﹤0.01% 1074
2023
Q4
$5.68K Hold
154
﹤0.01% 1047
2023
Q3
$3.12K Hold
154
﹤0.01% 1111
2023
Q2
$3.15K Hold
154
﹤0.01% 1140
2023
Q1
$2.32K Hold
154
﹤0.01% 1146
2022
Q4
$3.67K Sell
154
-700
-82% -$20.3K ﹤0.01% 1159
2022
Q3
$30.1K Buy
854
+700
+455% +$29.7K ﹤0.01% 904
2022
Q2
$5.38K Hold
154
﹤0.01% 1148
2022
Q1
$7.61K Hold
154
﹤0.01% 1140
2021
Q4
$11.9K Hold
154
﹤0.01% 1142
2021
Q3
$16.5K Hold
154
﹤0.01% 1013
2021
Q2
$20.5K Sell
154
-1,942
-93% -$226K ﹤0.01% 942
2021
Q1
$260K Buy
2,096
+1,693
+420% +$257K 0.02% 508
2020
Q4
$56.9K Buy
+403
New +$44.7K ﹤0.01% 758

Other funds holding TWST

Leonteq Securities AG's TWST Position: Q2 2026 in Review

Leonteq Securities AG reduced its Twist Bioscience (TWST) stake by 11% in Q2 2026, selling an estimated $130 and leaving 17 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Leonteq Securities AG first reported a position in TWST in Q4 2020 and has held it in 21 quarters since. The position peaked at $260K in Q1 2021. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Leonteq Securities AG held 17 shares of Twist Bioscience worth $1.75K as of Q2 2026.
  • Leonteq Securities AG sold 2 Twist Bioscience shares in Q2 2026, an estimated $130.
  • Twist Bioscience made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1158 holding.
  • Leonteq Securities AG first reported a position in Twist Bioscience in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities AG's Twist Bioscience position peaked at $260K in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.